2/7/2014 9:04:47 AM
TARRYTOWN, N.Y., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (PGNX), an oncology company focused on the development of innovative approaches to targeting and treating cancer, announced today that Mark R. Baker, CEO of Progenics, will present at the 16th Annual BIO CEO & Investor Conference which will be held February 10th and 11th at the Waldorf Astoria Hotel in New York City. The presentation will take place on Monday, February 10th at 3:00 PM EST.
Help employers find you! Check out all the jobs and post your resume.
comments powered by